The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.
Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.
The English language version is always the official and authoritative version of this website.
NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.
Synopsis As Introduced Creates the Mental Health Drug Open Access Authorization Act. Provides that the Children's Health Insurance Program, the Medicaid program, the pharmaceutical assistance program under the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act, and other State prescription drug assistance programs may not use or require the use of a prior authorization procedure in connection with the dispensing of a prescription drug, or reimbursement for the dispensing of a drug, classified as a central nervous system drug or prescribed for the treatment of mental illness. Amends the Children's Health Insurance Program Act, the Illinois Public Aid Code, and the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act to provide that health benefits coverage, medical assistance, and pharmaceutical assistance provided under those Acts are subject to the Mental Health Drug Prior Authorization Act. Effective immediately.
House Floor Amendment No. 1 Replaces everything after the enacting clause. Creates the Mental Health Drug Open Access Authorization Act and amends the Children's Health Insurance Program Act, the Illinois Public Aid Code, and the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act. Contains provisions substantially similar to those of House Bill 2449 as introduced, but with changes that include the following: (1) makes changes concerning legislative findings and the purpose of the Mental Health Drug Open Access Authorization Act; (2) adds a definition of "cross-indication" (replacing a definition of "cross-indicated"); (3) changes a reference to "the AMA Drug Evaluations" to "AHFS Drug Information"; (4) provides that nothing in the Mental Health Drug Open Access Authorization Act precludes prior authorization requirements on dosages that exceed those established by the FDA; and (5) provides that State agencies are not prevented from implementing restrictions other than prior authorization requirements for the purpose of ensuring the appropriate use of medications. Effective immediately.
Fiscal Note (H-AM1) (Department of Public Aid)
The fiscal impact, as amended, is approximately $15 million.
State Debt Impact Note (H-AM1) (Economic and Fiscal Commission)
This site is maintained for the Illinois General Assembly
by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706
Contact ILGA Webmaster